Inventor · disambiguated record
Peter Blumbergs
Also filed as: BLUMBERGS PETER
19 granted patents·5 pending applications·426 citations·filing 1985–2013
96Inventor score
Top patents by PatentIndex Score
24 records- 0197US7078518B2Forms of 5-AzacytidinePHARMION CORP·Filed 2005·Granted Jul 18, 2006·55 cites·5 claims
- 0296US6887855B2Forms of 5-azacytidineASH STEVENS INC·Filed 2003·Granted May 3, 2005·63 cites·8 claims
- 0395US7700770B2Methods for isolating crystalline form I of 5-azacytidineCELGENE CORP·Filed 2005·Granted Apr 20, 2010·27 cites·8 claims
- 0495US6943249B2Methods for isolating crystalline Form I of 5-azacytidinePHARMION CORP·Filed 2003·Granted Sep 13, 2005·68 cites·18 claims
- 0594US8058424B2Synthesis of 5-azacytidineIONESCU DUMITRU·Filed 2010·Granted Nov 15, 2011·28 cites·31 claims
- 0694US7772199B2Forms of 5-azacytidineCELGENE CORP·Filed 2006·Granted Aug 10, 2010·29 cites·2 claims
- 0794US7038038B2Synthesis of 5-azacytidineASH STEVENS INC·Filed 2003·Granted May 2, 2006·64 cites·26 claims
- 0893US8211862B2Pharmaceutical compositions comprising crystal forms of 5-azacytidineIONESCU DUMITRU·Filed 2010·Granted Jul 3, 2012·17 cites·40 claims
- 0993US7858774B2Synthesis of 5-azacytidinePHARMION LLC·Filed 2008·Granted Dec 28, 2010·39 cites·27 claims
- 1082US8614313B2Pharmaceutical compositions comprising forms of 5-azacytidineIONESCU DUMITRU·Filed 2012·Granted Dec 24, 2013·1 cites·13 claims
- 1182US4617394A4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolinesUS ARMY·Filed 1985·Granted Oct 14, 1986·19 cites·5 claims
- 1280US8481715B2Methods for isolating crystalline form I of 5-azacytidineIONESCU DUMITRU·Filed 2012·Granted Jul 9, 2013·3 cites·12 claims
- 1379US8513406B2Pharmaceutical compositions comprising forms of 5-azacytidineIONESCU DUMITRU·Filed 2012·Granted Aug 20, 2013·2 cites·13 claims
- 1472US9192620B2Pharmaceutical compositions comprising forms of 5-azacytidinePHARMION LLC·Filed 2013·Granted Nov 24, 2015·0 cites·17 claims
- 1564US6989386B2Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making sameASH STEVENS INC·Filed 2003·Granted Jan 24, 2006·3 cites·68 claims
- 1662US8779117B2Pharmaceutical compositions comprising 5-azacytidine monohydrateIONESCU DUMITRU·Filed 2010·Granted Jul 15, 2014·0 cites·17 claims
- 1761US8975392B2Methods for isolating crystalline form I of 5-azacytidinePHARMION LLC·Filed 2013·Granted Mar 10, 2015·0 cites·21 claims
- 1861US2006247432A1Synthesis of 5-AzacytidineIONESCU DUMITRU·Filed 2006·Application pending·0 cites
- 1957US2012029181A1Synthesis of 5-azacytidineIONESCU DUMITRU·Filed 2011·Application pending·0 cites
- 2052US2006079531A1Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making sameASH STEVENS·Filed 2005·Application pending·0 cites
- 2151US2005084488A1Asparagine deaminase catalytic antibodiesFiled 2004·Application pending·0 cites
- 2249US5296589AHydrogenation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-D-arabinofuranosyl)adenineASH STEVENS INC·Filed 1992·Granted Mar 22, 1994·5 cites·6 claims
- 2349US2007219204A1Pharmaceutically active ornitihine derivatives, ammonium salts thereof and methods of making sameASH STEVENS·Filed 2006·Application pending·0 cites
- 2435US5110919AProcess for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediatesASH STEVENS INC·Filed 1989·Granted May 5, 1992·3 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →